Jody Lawrence - Concepedia

Author

Jody Lawrence

University of California, San Francisco ORCID

Also Known As

J Josh Lawrence, J P Lawrence, J. Josh Lawrence, J. Lawrence, Janet S Lawrence, Javier R. Lama, Jody Lawrence

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco Stanford University Merck & Co., Inc., Rahway, NJ, USA (United States)San Francisco General Hospital Stanford Medicine

About

Jody Lawrence is an author at University of California, San Francisco specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	118
2	Immunology	2	2	94
3	Health Sciences	1	1	11
4	Pathology	1	1	24
5	Pharmacology	1	1	11

Jody Lawrence

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Frequency of Class I HLA-Restricted Anti-HIV CD8+ T Cells in Individuals Receiving Highly Active Antiretroviral Therapy (HAART) Clive M. Gray, Jody Lawrence, Jonathan Schapiro, The Journal of Immunology	1999	268
Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency Virus Jody Lawrence, Douglas L. Mayers, Katherine Huppler Hullsiek, New England Journal of Medicine	2003	265
Human Immunodeficiency Virus Type 1 Protease Genotypes and In Vitro Protease Inhibitor Susceptibilities of Isolates from Individuals Who Were Switched to Other Protease Inhibitors after Long-Term Saquinavir Treatment Mark A. Winters, Jonathan Schapiro, Jody Lawrence, Journal of Virology	1998	102
Lopinavir/Ritonavir Affects Pharmacokinetic Exposure of Artemether/Lumefantrine in HIV-Uninfected Healthy Volunteers Polina German, Sunil Parikh, Jody Lawrence, JAIDS Journal of Acquired Immune Deficiency Syndromes	2009	86
A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV‐Specific Immunizations, and Interleukin‐2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024) J Michael Kilby, R. Pat Bucy, Donna Mildvan, The Journal of Infectious Diseases Antiretroviral TherapyTreatment And PreventionHuman RetrovirusImmunodeficienciesImmunology	2006	83
A Multi-Investigator/Institutional DNA Bank for AIDS-Related Human Genetic Studies: AACTG Protocol A5128 David W. Haas, G. Wilkinson, Daniel R. Kuritzkes, HIV Clinical Trials	2003	66
Risk Factors for Primary Clostridium difficile Infection; Results From the Observational Study of Risk Factors for Clostridium difficile Infection in Hospitalized Patients With Infective Diarrhea (ORCHID) Kerrie Davies, Jody Lawrence, Claire Berry, Frontiers in Public Health	2020	65
Clinical Resistance Patterns and Responses to Two Sequential Protease Inhibitor Regimens in Saquinavir and Reverse Transcriptase Inhibitor–Experienced Persons Jody Lawrence, Jonathan Schapiro, Mark A. Winters, The Journal of Infectious Diseases	1999	60
A randomized comparison of two instruments for measuring self-reported antiretroviral adherence Sharon Mannheimer, Lisa Thackeray, Katherine Huppler Hullsiek, AIDS Care	2008	56
Efficacy and safety of pentavalent rotavirus vaccine in Japan Satoshi Iwata, Shuji Nakata, Susumu Ukae, Human Vaccines & Immunotherapeutics	2013	51

Page 1